Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: May 2013

DURECTCorp. (DRRX) Starts Presentation at 2nd Annual Marcum MicroCap Conference

DURECTCorp., a specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, has a line of late-stage development programs including Remoxy®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil. The company’s proprietary oral, transdermal and injectable depot delivery technologies enable new indications … Continue reading

Posted in Marcum MicroCap | Leave a comment

SG Blocks, Inc. (SGBX) Starts Presentation at 2nd Annual Marcum MicroCap Conference

SG Blocks redesigns, repurposes and converts heavy-gauge steel cargo shipping containers into green building blocks for application in commercial, industrial and residential building construction primarily in the United States. The company also offers engineering and project management services related to … Continue reading

Posted in Marcum MicroCap | Leave a comment

Sirona Biochem Corp. (SRBCF) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Sirona Biochem is a biotechnology company developing diabetes therapeutics, skin depigmenting and anti-aging agents for cosmetic use, biological ingredients and cancer vaccine antigens. The company utilizes a proprietary chemistry technique to improve pharmaceutical properties of carbohydrate-based molecules. SRBCF is the … Continue reading

Posted in Marcum MicroCap | Leave a comment

OTC Markets Group, Inc. (OTCM) Starts Presentation at 2nd Annual Marcum MicroCap Conference

OTC Markets Group operates Open, Transparent and Connected financial marketplaces for U.S. and global securities utilizing its OTC Link® ATS, which connects a network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. These securities … Continue reading

Posted in Marcum MicroCap | Leave a comment

LeMaitre Vascular, Inc. (LMAT) Starts Presentation at 2nd Annual Marcum MicroCap Conference

LeMaitre Vascular, a provider of devices for the treatment of peripheral vascular disease, develops, manufactures and markets disposable and implantable vascular devices to address the needs of vascular surgeons. LMAT’s products include embolectomy catheters; occlusion catheters; perfusion catheters; carotid shunts … Continue reading

Posted in Marcum MicroCap | Leave a comment

Ddd Group Plc (DDDGF) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Ddd Group is engaged in creating s3 dimension (3D) visual experiences through its TriDefTM3D solutions, which convert 2D to 3D automatically, and enable delivery to 3D TVs, PCs and mobile devices. Leading brands, including Intel, Samsung, LG Electronics and Sony, … Continue reading

Posted in Marcum MicroCap | Leave a comment

Synthetic Biologics, Inc. (SYN) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Synthetic Biologics is a biotechnology company focused on the development of biologics for the prevention and treatment of serious infectious diseases. The company is developing an oral enzyme for the prevention of C. difficile infections, and a series of monoclonal … Continue reading

Posted in Marcum MicroCap | Leave a comment

Trio Resources, Inc. (TRII) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Trio Resources is organized to hold assets in the mining industry, targeting older mining camps with residual value. The company’s mission is to conduct an exploration program in conjunction with milling initiatives to monetize its existing above-ground mineralized material on-site … Continue reading

Posted in Marcum MicroCap | Leave a comment

GSE Systems, Inc. (GVP) Starts Presentation at 2nd Annual Marcum MicroCap Conference

GSE Systems provides a wide range of simulation, training and engineering solutions to the energy and process industries. The company’s products and services are tailored to meet specific client requirements such as scope, budget and timeline. GVP has more than … Continue reading

Posted in Marcum MicroCap | Leave a comment

Coronado Biosciences Inc. (CNDO) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Coronado Biosciences is focused on developing novel immunotherapy biologic agents. The company’s two principal pharmaceutical product candidates in clinical development are: TSO (Trichuris suis ova or CNDO-201), a biologic for the treatment of autoimmune diseases such as Crohn’s disease, ulcerative … Continue reading

Posted in Marcum MicroCap | Leave a comment